For decades, the hemophilia community has worked together towards a brighter future… for our families, and for the next generation. Now the time has come for us to pass on something powerful: knowledge.
My Life, Our Future is a nationwide campaign for progress in hemophilia. Leaders in our community have come together to offer genotyping at no or very low cost, so that you may gain a deeper understanding of your hemophilia today, while helping to advance the breakthrough treatments of tomorrow.
This incredible initiative will become available in 2013. Until then, we invite you to learn more via the informational video below and to sign up to receive updates from the National Hemophilia Foundation.
Genotyping is the process of identifying the genetic code responsible for an individual's hemophilia. Much like a fingerprint, your genotype can provide meaningful information about your hemophilia to you and your doctor. The process begins with a small blood test, and results in personalized knowledge. Genotyping has the power to:
A not-for-profit organization representing over 130 Hemophilia Treatment Centers, the American Thrombosis and Hemostasis Network will ensure the collection and secure storage of information, while also supporting centers who offer this service.
A committed community partner whose mission is to empower people with hemophilia to live the lives they choose, Biogen Idec Hemophilia is honored to provide financial support and leadership. We are the world's oldest independent biotechnology company, backed by over 30 years of scientific innovation and a passion for progress.